MedPath

Acupuncture for Obesity on Serum Metabolic Parameters

Not Applicable
Completed
Conditions
Obesity
Interventions
Device: Real acupuncture
Device: Sham acupuncture
Registration Number
NCT02066090
Lead Sponsor
Kyung Hee University Hospital at Gangdong
Brief Summary

This research is planned to build a basis about the effect of acupuncture on serum metabolic parameters in pre-menopausal obese women with economic evaluation.

Detailed Description

It is consisted with two sub research.

First, clinical research to assess the effect of acupuncture for obesity on serum metabolic parameters will be processed with randomized, patient-assessor blinding, and sham-acupuncture controlled study design. 120 subjects would be collected and divided into two groups(experimental and placebo, 60 subjects each). Experimental group will undergo with real acupuncture treatment(manual acupuncture + electroacupuncture) twice a week, for 6 weeks. The effect on serum metabolic parameters will be assessed at 0 and 6 weeks.

Second is qualitative research to make a basis through the evaluation of economic efficacy and patients' satisfaction with acupuncture treatment for obesity.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • volunteers through announcements and advertisements
  • premenopausal adult women (19 years of age or more)
  • clinical diagnosis of obesity (Body mass index: 25 kg/m2 or more)
Exclusion Criteria
  • previously or currently having endocrine disease such as hypothyroidism or Cushing's syndrome, heart disease, lung disease, diabetes, malignant tumor, cholelithiasis, severe kidney impairment, severe liver impairment, anorexia nervosa or hyperorexia
  • experience of taking medicines which might affect body weight and the concentration of serum metabolic parameters such as anorectic, laxative, oral steroid, thyroid hormone, amphetamine, cyproheptadine, phenothiazine, or medicines affecting absorption, metabolism, and excretion in the past 3 months
  • experience of taking beta-blocker or diuretic for the treatment of hypertension in the past 3 months
  • surgical treatment for the treatment of obesity
  • currently or might be pregnant or breast-feeding
  • experience of taking other experimental medicines in the past month
  • weight loss of 10% or more of previous body weight in the past 6 months
  • who stopped smoking in the past 3 months or who have irregular smoking habit
  • pacemaker
  • currently receiving any treatment for obesity
  • other inadequate subjects assessed by the study investigators

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Real acupunctureReal acupuncturemanual acupuncture + electroacupuncture, twice a week, for 6 weeks
Sham acupunctureSham acupuncturesham acupuncture + placebo acupuncture without electrical stimulation, twice a week, for 6 weeks
Primary Outcome Measures
NameTimeMethod
change in serum metabolic profilebefore treatment at week1 (baseline) and after treatment at week6 (endpoint)
Secondary Outcome Measures
NameTimeMethod
change in hip circumferencebaseline, 1, 2, 3, 4, 5, and 6 weeks
change in Beck Depression Index (BDI)baseline and 6 weeks
change in International Physical Activity Questionnaire (IPAQ)baseline and 6 weeks
change in muscle massbaseline, 1, 2, 3, 4, 5, and 6 weeks

using bioelectrical impedance analysis (BIA)

change in waist circumferencebaseline, 1, 2, 3, 4, 5, and 6 weeks
change in Social Readjustment Rating Scale (SRRS)baseline and 6 weeks
change in body weightbaseline, 1, 2, 3, 4, 5, and 6 weeks

using bioelectrical impedance analysis (BIA)

change in Stress Response Inventory (SRI)baseline and 6 weeks
heart rate variability (HRV)just before treatment at visit1(baseline), 10 minutes after treatment at visit1, just before treatment at visit12 (6 weeks), 10 minutes after treatment at visit12(end point)
change in body fat massbaseline, 1, 2, 3, 4, 5, and 6 weeks

using bioelectrical impedance analysis (BIA)

change in Fatigue Severity Scale (FSS)baseline, 1, 2, 3, 4, 5, and 6 weeks
number of participants with adverse eventsup to the end of study

* assessment of severity: mild, moderate, severe

* assessment of relation: definitely related, probably related, possibly related, probably not related, definitely not related, unknown

Trial Locations

Locations (1)

Kyung Hee University Korean Medicine Hospital at Gangdong

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath